A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients’ blood has been developed by scientists at the University of Campinas (UNICAMP) in Brazil.
The method combines mass spectrometry, which can identify tens of thousands of molecules present in blood serum, with an artificial intelligence algorithm capable of finding patterns associated with diseases of viral, bacterial, fungal and even genetic origin.
“We used infection by Zika virus as a model to develop the platform and showed that in this case, diagnostic accuracy exceeded 95%. One of the main advantages is that the method doesn’t lose sensitivity even if the virus mutates,” said Melo’s supervisor Rodrigo Ramos Catharino, principal investigator for the project. Catharino is a professor at UNICAMP’s School of Pharmaceutical Sciences (FCF) and head of its Innovare Biomarker Laboratory.
Another strength of the platform, he added, is the capacity to identify positive cases of Zika even in blood serum analyzed 30 days after the start of infection, when the acute phase of the disease is over.
“None of the currently available diagnostic kits has the sensitivity to detect infection by Zika after the end of the acute phase. The method we developed could be useful to analyze transfusion blood bags, for example,” Catharino said.
Development and validation of the platform involved analysis of blood samples from 203 patients treated at UNICAMP’s general and teaching hospital. Of these, 82 were diagnosed with Zika by the method currently considered the gold standard in this field: real-time polymerase chain reaction (RT-PCR), which detects viral RNA in body fluids during the acute phase of the infection.
The other 121 patients were the control group. Approximately half had the same symptoms as the group that tested positive for Zika, such as fever, joint pain, conjunctivitis and rash, but had negative RT-PCR results for Zika. The rest had no symptoms and also tested negative or were diagnosed with dengue.
All collected samples were analyzed in a mass spectrometer, a device that acts as a kind of molecular weighing scale, sorting molecules according to their mass.
“We identified some 10,000 different molecules in the patients’ serum, including lipids, peptides, and fragments of DNA and RNA. Among these metabolites, there were particles produced both by Zika and by the patient’s immune system in response to the infection,” Catharino said.
All the data obtained in the spectrometry analysis of both the group that tested positive for Zika and the control group were then fed into a computer program running a random-forest machine learning algorithm. This type of artificial intelligence tool is capable of analyzing a large amount of data by specific statistical methods in search of patterns that can be used as a basis for classification, prediction, decision making, modeling and so on.
“The algorithm separates samples randomly, determines which one will be the training group and the blind group, and then carries out testing and validation. At the end, it tells us whether with that number of samples it was possible to obtain a set of metabolic markers capable of identifying patients infected by Zika,” Catharino explained.
Each new set of patient data fed into the program enhances its learning capacity and makes it more sensitive, he went on. In the case of Zika, a panel of 42 biomarkers was established as a specific key to identifying the virus. Twelve of these were found by the algorithm to be highly prevalent in the blood of patients who tested positive for the disease.
“In this platform, it isn’t important to know a lot individually about each of the molecules that serve as markers of the infection. It’s the set that matters and that will tell us with a high level of accuracy whether we’re looking at Zika. Moreover, even if the virus mutates, the program adapts and changes too. It’s not a static methodology,” Catharino said.
The UNICAMP group is currently performing tests to evaluate the platform’s capacity to diagnose systemic diseases caused by fungi. They also plan to test how well it detects bacterial and genetic diseases. Anderson de Rezende Rocha, a professor at the same university’s Institute of Computing (IC-UNICAMP), is collaborating on the research.
In the cloud
In theory, any laboratory equipped with a mass spectrometer could use the new diagnostic platform developed at UNICAMP. Mass spectrometers are routinely used in procedures such as measuring vitamin D and screening blood spots from newborns to detect metabolic diseases via the heel prick test.
“Our proposal is to make the platform available in the cloud, so that it can be downloaded to any mass spectrometer anywhere in the world. Data analysis can be performed online. Whether it would be free or paid is yet to be defined,” Catharino said.
The Latest on: Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence diagnostics
- Georgia Tech researchers using AI to develop early diagnostic test for ovarian canceron February 22, 2024 at 3:54 pm
That same year, more than 13,000 women died of the disease. But now researchers at Georgia Tech are developing a diagnostic test that could save lives using artificial intelligence. “I don’t think ...
- In Vitro Diagnostics Markets Revolutionized by Artificial Intelligence and Multiplex Testing: A Comprehensive 2023-2027 Forecaston February 22, 2024 at 9:06 am
The "Smart In-Vitro Diagnostics - Artificial Intelligence for In Vitro Diagnostics Markets by Application, by Technology and by User with Executive and Consultant Guides 2023-2027" report has been ...
- Artificial intelligence used in Vt. dental practiceson February 21, 2024 at 6:22 am
Artificial intelligence is no longer just a concept, but a real technology being implemented in many facets of life. One sector starting to use AI in Vermont is dentistry.
- ARTIFICIAL INTELLIGENCE: MATTERS ARISINGon February 20, 2024 at 3:46 pm
“Understanding emotions and interpreting personal touches are quintessential human traits that arise from our complex neural networks and emotional intelligence. AI might be able to recognise facial ...
- From Construction To AI Diagnostics, Here Are 5 Areas Where Seed Investors Are Most Activeon February 16, 2024 at 6:36 am
Using seed-funding data, we looked at today’s cohort of very young funded companies and pieced together a sense of the technologies startup investors see most impacting our lives in future years.
- Lawmakers explore how artificial intelligence can boost care for vetson February 15, 2024 at 2:59 am
the chief technology officer and chief artificial intelligence officer in VA’s Office of Information and Technology. VA is already leveraging AI in a number of ways, from enhancing diagnostic accuracy ...
- Artificial Intelligence (AI) In Medical Diagnostics Market Worth $3.7 Billion By 2028 | Marketsandmarketson February 14, 2024 at 6:35 pm
"Browse 401 market data Tables and 46 Figures spread through 341 Pages and in-depth TOC on "Artificial Intelligence (AI) in Medical Diagnostics Market by Modality (CT, X-Ray, MRI, Ultrasound ...
- Artificial Intelligence (AI) In Diagnostics Market Demand To Hit $11.9 Bn By 2030 | Globally At 40.6% CAGRon February 13, 2024 at 9:31 pm
Artificial Intelligence In Diagnostics Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, February 14 ...
- The Role of Artificial Intelligence in Enhancing Healthcare: A Promising Futureon February 13, 2024 at 9:18 am
Welcome to the future of healthcare, where artificial intelligence is poised to revolutionize the way we diagnose, treat, and even prevent diseases. From robots performing surgeries with unparalleled ...
via Bing News